Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter Blurb re Patent Reform

Letter Blurb re Patent Reform

posted on Jan 29, 2008 09:08AM
Wondering if that blurb was also included to temper expectations about the amounts of the settlements.  IMO, it implies that concerns over the pending patent reform and its impact on licensing, may have incentivized TPL/PTSC to settle ASAP rather than chance that those changes might impact the lawsuits, even if indirectly.
Share
New Message
Please login to post a reply